D. Gilliland

D. Gilliland

Director/Board Member chez NUVALENT, INC.

Fortune : 2 M $ au 31/03/2024

69 ans
Health Technology
Commercial Services
Consumer Services

Profil

D.
Gary Gilliland
is currently an Independent Director at Laboratory Corp.
of America Holdings and Nuvalent, Inc. He is also a Member of the American Academy of Arts & Sciences, the National Academy of Medicine (United States), the Association of American Physicians, and the American Society of Clinical Investigation.
Previously, he served as the President & Director of the Fred Hutchinson Cancer Research Center from 2015 to 2020.
He was also the Director-Leukemia Program at Dana-Farber from 2002 to 2009 and the Director-Cancer Stem Cell Program at the Harvard Stem Cell Institute in 2009.
Additionally, he held positions as a Senior Vice President at Merck & Co., Inc. from 2009 to 2013 and as a Senior Vice President at Merck Research Laboratories Massachusetts LLC from 2009 to 2013.
He was a Senior Vice President at The University of Pennsylvania Health System and a Senior Vice President at the Trustees of the University of Pennsylvania from 2013 to 2015.
He was a Vice Dean & Professor at the Perelman School of Medicine from 2013 to 2020.
Gilliland's education includes a doctorate from the University of California, Los Angeles, an undergraduate degree from the University of California, Davis, and another doctorate from the University of California, San Francisco.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
07/02/2024 8 712 ( 0,01% ) 2 M $ 31/03/2024
15/06/2023 0 ( -.--% ) - $ 31/03/2024

Postes actifs de D. Gilliland

SociétésPosteDébut
LABORATORY CORPORATION OF AMERICA HOLDINGS Director/Board Member 01/04/2014
NUVALENT, INC. Director/Board Member 01/01/2021
Corporate Officer/Principal -
Corporate Officer/Principal -
American Society of Clinical Investigation Corporate Officer/Principal -
Corporate Officer/Principal -
Tous les postes actifs de D. Gilliland

Anciens postes connus de D. Gilliland

SociétésPosteFin
President 01/02/2020
Perelman School of Medicine Corporate Officer/Principal 01/01/2020
Corporate Officer/Principal 01/01/2015
░░░░░ ░░░░░ ░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de D. Gilliland

Formation de D. Gilliland

University of California, Los Angeles Doctorate Degree
University of California, Davis Undergraduate Degree
The University of California, San Francisco Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de D. Gilliland

Relations

100 +

Relations au 1er degré

20

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées3
LABORATORY CORPORATION OF AMERICA HOLDINGS

Health Services

MERCK & CO., INC.

Health Technology

NUVALENT, INC.

Health Technology

Entreprise privées12

Commercial Services

Miscellaneous

Commercial Services

Commercial Services

Commercial Services

Health Technology

Health Services

American Society of Clinical Investigation

Health Technology

Miscellaneous

Health Technology

Commercial Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. D. Gilliland